Jim Klostergaard
Affiliations: | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Molecular Biology, OncologyGoogle:
"Jim Klostergaard"Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Liang Y, Yu D, Perez-Soler R, et al. (2017) TRIB2 contributes to cisplatin resistance in small cell lung cancer. Oncotarget. 8: 109596-109608 |
| Sahin IH, Klostergaard J. (2015) CD44 as a drug delivery target in human cancers: where are we now? Expert Opinion On Therapeutic Targets. 19: 1587-91 |
| Lee SJ, Ghosh SC, Han HD, et al. (2012) Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4114-21 |
| Klostergaard J, Seeney CE. (2012) Magnetic nanovectors for drug delivery. Nanomedicine : Nanotechnology, Biology, and Medicine. 8: S37-50 |
| Ghosh SC, Neslihan Alpay S, Klostergaard J. (2012) CD44: a validated target for improved delivery of cancer therapeutics. Expert Opinion On Therapeutic Targets. 16: 635-50 |
| Klostergaard J, Seeney CE. (2012) Magnetic nanovectors for drug delivery. Maturitas. 73: 33-44 |
| Seeney C, Ojwang JO, Weiss RD, et al. (2012) Magnetically vectored platforms for the targeted delivery of therapeutics to tumors: history and current status. Nanomedicine (London, England). 7: 289-99 |
| Chen X, Fokt I, Skora S, et al. (2012) Abstract C65: Drug-tolerant cancer cells show reduced tumor-initiating capacity: Depletion of CD44+ cells and evidence for epigenetic mechanisms Cancer Research. 72: C65-C65 |
| Yan H, Chen X, Zhang Q, et al. (2011) Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms. Plos One. 6: e24397 |
| Galer CE, Sano D, Ghosh SC, et al. (2011) Hyaluronic acid-paclitaxel conjugate inhibits growth of human squamous cell carcinomas of the head and neck via a hyaluronic acid-mediated mechanism Oral Oncology. 47: 1039-1047 |